B. Değertekin, “Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience”, Turkish Journal of Gastroenterology, vol. 31, no. 12, pp. 883–893, Jan. 2020.